Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate Student Research Awards (USRA)

University of Toronto

$6,000.00

Examining the use of Cannabis for the Treatment of Restless Legs Syndrome

FY 2026-27

Summary
Restless Legs Syndrome (RLS) is a disorder that causes uncomfortable sensations in the legs, and significantly impacts sleep and quality of life. Current treatment options can have unwanted side effects (e.g. nausea, dizziness, or impulse control disorders) or can be associated with incomplete treatment responses. As a result, RLS is often inadequately treated, indicating an urgent need for alternative treatment options. Cannabis has been used by some RLS patients as a treatment due to its painkilling and sedating effects, however, there has never been a clinical research trial investigating cannabis in patients with RLS. This pilot study will be conducted as a randomized, double blind, parallel group, controlled trial. Cannabis will be administered as an adjunctive therapy; thus, patients will not be required to discontinue their current RLS therapies. In our study, thirty participants with RLS will be randomized (1:1) to receive cannabis vs. placebo during the 8-week study period. Initially, there will be a 4-week titration period; starting at 1mL per night, the study drug (i.e. cannabis vs. placebo) will be titrated each week to a maximum of 8mL per night. After the 4-week titration period, the dose will be kept the same for the remaining 4 weeks. Feasibility and safety will be evaluated; we will also examine questionnaire data and home sleep testing at baseline and the 8-week follow-up. If cannabis is found to be feasible and safe for the management of RLS symptoms, the results of this study will be used to design a larger trial that will be adequately powered to determine the efficacy of using cannabis to treat RLS. Cannabis may provide the much-needed relief sought out by patients who are currently suffering from this debilitating condition.
Program
Undergraduate Student Research Awards (USRA)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
571583
Name
Ali Hephzibah Ojonuyo
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Examining the use of Cannabis for the Treatment of Restless Legs Syndrome
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$6,000
Cihrequipment2
$0
Programname2
Undergraduate Student Research Awards (USRA)
Keyworddelim
Disorder; Legs; Quality Of Life; Restless Legs Syndrome; Sleep
Abstract
Restless Legs Syndrome (RLS) is a disorder that causes uncomfortable sensations in the legs, and significantly impacts sleep and quality of life. Current treatment options can have unwanted side effects (e.g. nausea, dizziness, or impulse control disorders) or can be associated with incomplete treatment responses. As a result, RLS is often inadequately treated, indicating an urgent need for alternative treatment options. Cannabis has been used by some RLS patients as a treatment due to its painkilling and sedating effects, however, there has never been a clinical research trial investigating cannabis in patients with RLS. This pilot study will be conducted as a randomized, double blind, parallel group, controlled trial. Cannabis will be administered as an adjunctive therapy; thus, patients will not be required to discontinue their current RLS therapies. In our study, thirty participants with RLS will be randomized (1:1) to receive cannabis vs. placebo during the 8-week study period. Initially, there will be a 4-week titration period; starting at 1mL per night, the study drug (i.e. cannabis vs. placebo) will be titrated each week to a maximum of 8mL per night. After the 4-week titration period, the dose will be kept the same for the remaining 4 weeks. Feasibility and safety will be evaluated; we will also examine questionnaire data and home sleep testing at baseline and the 8-week follow-up. If cannabis is found to be feasible and safe for the management of RLS symptoms, the results of this study will be used to design a larger trial that will be adequately powered to determine the efficacy of using cannabis to treat RLS. Cannabis may provide the much-needed relief sought out by patients who are currently suffering from this debilitating condition.
Competitiondate
202605
Approvedterm2
0 yr 4 mths
Pinamesdelim
Ali, Hephzibah Ojonuyo
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $6,000~ $0~